

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of autophagic vacuole assembly (GO:2000785) | 4.59498461 |
| 2 | cellular response to exogenous dsRNA (GO:0071360) | 4.57334798 |
| 3 | negative regulation of macroautophagy (GO:0016242) | 4.45658815 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.34090150 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 4.32558913 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.27661616 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.21157945 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14205979 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.14070367 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.14070367 |
| 11 | cytidine deamination (GO:0009972) | 4.11719185 |
| 12 | cytidine metabolic process (GO:0046087) | 4.11719185 |
| 13 | cytidine catabolic process (GO:0006216) | 4.11719185 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.96062740 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.96062740 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 3.96062740 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 3.96062740 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 3.96062740 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.96062740 |
| 20 | regulation of vacuole organization (GO:0044088) | 3.82418479 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.74075014 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.73793734 |
| 23 | microglial cell activation (GO:0001774) | 3.69586745 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.64037192 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.56970406 |
| 26 | negative regulation of cell killing (GO:0031342) | 3.56970406 |
| 27 | respiratory burst (GO:0045730) | 3.52530903 |
| 28 | B cell receptor signaling pathway (GO:0050853) | 3.50866395 |
| 29 | positive regulation of granulocyte differentiation (GO:0030854) | 3.50371574 |
| 30 | positive regulation of B cell differentiation (GO:0045579) | 3.49733785 |
| 31 | mast cell activation (GO:0045576) | 3.43011324 |
| 32 | response to peptidoglycan (GO:0032494) | 3.38267961 |
| 33 | neutrophil activation (GO:0042119) | 3.36262092 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 3.31688954 |
| 35 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.30917072 |
| 36 | response to type I interferon (GO:0034340) | 3.28858063 |
| 37 | myeloid cell activation involved in immune response (GO:0002275) | 3.26440402 |
| 38 | type I interferon signaling pathway (GO:0060337) | 3.24616234 |
| 39 | cellular response to type I interferon (GO:0071357) | 3.24616234 |
| 40 | T cell migration (GO:0072678) | 3.24332680 |
| 41 | granulocyte activation (GO:0036230) | 3.20655599 |
| 42 | negative regulation of T cell mediated immunity (GO:0002710) | 3.19880561 |
| 43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.17772716 |
| 44 | positive thymic T cell selection (GO:0045059) | 3.16109906 |
| 45 | regulation of B cell differentiation (GO:0045577) | 3.14022070 |
| 46 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12048523 |
| 47 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.07433190 |
| 48 | cellular extravasation (GO:0045123) | 3.06280278 |
| 49 | positive regulation of antigen processing and presentation (GO:0002579) | 3.06178063 |
| 50 | myeloid dendritic cell activation (GO:0001773) | 3.03284563 |
| 51 | megakaryocyte development (GO:0035855) | 2.99672345 |
| 52 | positive regulation of interferon-alpha production (GO:0032727) | 2.95847285 |
| 53 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.91890540 |
| 54 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91753808 |
| 55 | negative regulation of interleukin-12 production (GO:0032695) | 2.91741220 |
| 56 | defense response to protozoan (GO:0042832) | 2.91672987 |
| 57 | mature B cell differentiation (GO:0002335) | 2.89356236 |
| 58 | regulation of female receptivity (GO:0045924) | 2.89240535 |
| 59 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.88336990 |
| 60 | activated T cell proliferation (GO:0050798) | 2.86036267 |
| 61 | regulation of hypersensitivity (GO:0002883) | 2.85675950 |
| 62 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85374739 |
| 63 | regulation of vitamin metabolic process (GO:0030656) | 2.85174764 |
| 64 | positive regulation of mast cell activation (GO:0033005) | 2.84230055 |
| 65 | positive T cell selection (GO:0043368) | 2.84224407 |
| 66 | regulation of interferon-alpha production (GO:0032647) | 2.83553939 |
| 67 | regulation of mast cell degranulation (GO:0043304) | 2.83529726 |
| 68 | negative thymic T cell selection (GO:0045060) | 2.82629185 |
| 69 | regulation of mast cell activation (GO:0033003) | 2.81379679 |
| 70 | response to host immune response (GO:0052572) | 2.80814164 |
| 71 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.80814164 |
| 72 | negative T cell selection (GO:0043383) | 2.80418386 |
| 73 | thrombin receptor signaling pathway (GO:0070493) | 2.80227832 |
| 74 | mature B cell differentiation involved in immune response (GO:0002313) | 2.80041974 |
| 75 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.79861406 |
| 76 | cellular response to interferon-beta (GO:0035458) | 2.79716161 |
| 77 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.78601719 |
| 78 | Peyers patch development (GO:0048541) | 2.78601719 |
| 79 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.77695497 |
| 80 | myeloid dendritic cell differentiation (GO:0043011) | 2.77101555 |
| 81 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.75878610 |
| 82 | tolerance induction (GO:0002507) | 2.75405207 |
| 83 | definitive hemopoiesis (GO:0060216) | 2.75180410 |
| 84 | actin nucleation (GO:0045010) | 2.74846411 |
| 85 | regulation of germinal center formation (GO:0002634) | 2.74283474 |
| 86 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.74018687 |
| 87 | regulation of gamma-delta T cell activation (GO:0046643) | 2.73527699 |
| 88 | leukocyte mediated cytotoxicity (GO:0001909) | 2.73337046 |
| 89 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.72545359 |
| 90 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.71727869 |
| 91 | natural killer cell mediated immunity (GO:0002228) | 2.71247188 |
| 92 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.71247188 |
| 93 | response to protozoan (GO:0001562) | 2.70755910 |
| 94 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.70660647 |
| 95 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.70040965 |
| 96 | macrophage activation (GO:0042116) | 2.69799994 |
| 97 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.69796017 |
| 98 | germinal center formation (GO:0002467) | 2.68998716 |
| 99 | interferon-gamma production (GO:0032609) | 2.68943130 |
| 100 | regulation of antigen processing and presentation (GO:0002577) | 2.68505293 |
| 101 | leukocyte aggregation (GO:0070486) | 2.68433494 |
| 102 | leukocyte degranulation (GO:0043299) | 2.67226411 |
| 103 | aggressive behavior (GO:0002118) | 2.66957435 |
| 104 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.66868807 |
| 105 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.66271002 |
| 106 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.65389428 |
| 107 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.64590022 |
| 108 | neutrophil mediated immunity (GO:0002446) | 2.64406181 |
| 109 | mast cell degranulation (GO:0043303) | 2.64237895 |
| 110 | mast cell activation involved in immune response (GO:0002279) | 2.64237895 |
| 111 | myeloid leukocyte activation (GO:0002274) | 2.63866572 |
| 112 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.63682891 |
| 113 | negative regulation of phagocytosis (GO:0050765) | 2.62000534 |
| 114 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.61197460 |
| 115 | positive regulation of mast cell degranulation (GO:0043306) | 2.60869213 |
| 116 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.60869213 |
| 117 | positive regulation of B cell activation (GO:0050871) | 2.60071728 |
| 118 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.59904534 |
| 119 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.59580521 |
| 120 | regulation of granulocyte differentiation (GO:0030852) | 2.58846552 |
| 121 | B cell mediated immunity (GO:0019724) | 2.58808228 |
| 122 | detection of other organism (GO:0098543) | 2.58292268 |
| 123 | sulfate transmembrane transport (GO:1902358) | 2.58123771 |
| 124 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.58044296 |
| 125 | NAD biosynthetic process (GO:0009435) | 2.57580085 |
| 126 | NIK/NF-kappaB signaling (GO:0038061) | 2.57093698 |
| 127 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.56687764 |
| 128 | B cell homeostasis (GO:0001782) | 2.56018648 |
| 129 | response to muramyl dipeptide (GO:0032495) | 2.54418433 |
| 130 | response to fungus (GO:0009620) | 2.54051862 |
| 131 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.53363017 |
| 132 | autophagic vacuole fusion (GO:0000046) | 2.53059540 |
| 133 | positive regulation of humoral immune response (GO:0002922) | 2.52989645 |
| 134 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.52299049 |
| 135 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.52124853 |
| 136 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.52104259 |
| 137 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.51120600 |
| 138 | response to interleukin-15 (GO:0070672) | 2.50650192 |
| 139 | sleep (GO:0030431) | 2.49644951 |
| 140 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.49446399 |
| 141 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.49440515 |
| 142 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.48924529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.91292186 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.27734445 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.72939467 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.90091503 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.72457166 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.72001438 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.68503203 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.67198067 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.59860932 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.50864442 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.50858996 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.49308088 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94886969 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.75361301 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.68425748 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.66265429 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54227290 |
| 18 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.47993643 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.47282556 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.37276594 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.25722380 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.15444529 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13566431 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.09539042 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09537990 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08176621 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06282999 |
| 28 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.94770771 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.94109305 |
| 30 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.93943398 |
| 31 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.93315657 |
| 32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92748784 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.91102542 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90867793 |
| 35 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.90272934 |
| 36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.89618362 |
| 37 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86531626 |
| 38 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84338496 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.80054129 |
| 40 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.76443990 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.68698751 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.67188294 |
| 43 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66313690 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65558020 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62668077 |
| 46 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.59633222 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59044391 |
| 48 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57444404 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57343822 |
| 50 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.52540616 |
| 51 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.52159547 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.51398891 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50912075 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.49742338 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49546032 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.47710200 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45576769 |
| 58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.45091874 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.44939811 |
| 60 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41454474 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40252997 |
| 62 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39335697 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.38096046 |
| 64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37596318 |
| 65 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30681724 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29932107 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29777840 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27178910 |
| 69 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.25433842 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25275011 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24290853 |
| 72 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.23217212 |
| 73 | MYC_22102868_ChIP-Seq_BL_Human | 1.21807019 |
| 74 | VDR_22108803_ChIP-Seq_LS180_Human | 1.19230260 |
| 75 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17561324 |
| 76 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.16384568 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14162755 |
| 78 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13672855 |
| 79 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13644054 |
| 80 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.12801566 |
| 81 | MAF_26560356_Chip-Seq_TH2_Human | 1.12325514 |
| 82 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.11446809 |
| 83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11084949 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10919263 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10919263 |
| 86 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09389337 |
| 87 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07872718 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07768046 |
| 89 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.07067526 |
| 90 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.06097759 |
| 91 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05976698 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03477133 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03444324 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01420331 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00756407 |
| 96 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99613756 |
| 97 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.98916089 |
| 98 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.97946740 |
| 99 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97725335 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96030255 |
| 101 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93627792 |
| 102 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.93470250 |
| 103 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.93003747 |
| 104 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92272296 |
| 105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91463436 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91309429 |
| 107 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.88285023 |
| 108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87997273 |
| 109 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87412891 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87102479 |
| 111 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86726459 |
| 112 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.86209184 |
| 113 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85569902 |
| 114 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.84465093 |
| 115 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.84251215 |
| 116 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.83680055 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81137696 |
| 118 | GATA3_26560356_Chip-Seq_TH1_Human | 0.80571810 |
| 119 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.79808603 |
| 120 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.79771792 |
| 121 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.79518604 |
| 122 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79002614 |
| 123 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.78888371 |
| 124 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.78146194 |
| 125 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.78126643 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77985060 |
| 127 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.77536792 |
| 128 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.77457917 |
| 129 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.76043680 |
| 130 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.75174853 |
| 131 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.71859949 |
| 132 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.71179412 |
| 133 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.70177591 |
| 134 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.69438021 |
| 135 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.68617890 |
| 136 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.68373902 |
| 137 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.66591300 |
| 138 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.65069197 |
| 139 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64907562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.50622467 |
| 2 | MP0005387_immune_system_phenotype | 3.08865843 |
| 3 | MP0001790_abnormal_immune_system | 3.08865843 |
| 4 | MP0003436_decreased_susceptibility_to | 2.96363977 |
| 5 | MP0003303_peritoneal_inflammation | 2.92004696 |
| 6 | MP0005671_abnormal_response_to | 2.91267384 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.71874868 |
| 8 | MP0001800_abnormal_humoral_immune | 2.69915252 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.69558578 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.69536450 |
| 11 | MP0000685_abnormal_immune_system | 2.69384159 |
| 12 | MP0009785_altered_susceptibility_to | 2.65984123 |
| 13 | MP0005025_abnormal_response_to | 2.64668365 |
| 14 | MP0002419_abnormal_innate_immunity | 2.64484955 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.50880573 |
| 16 | MP0003724_increased_susceptibility_to | 2.43973667 |
| 17 | MP0002723_abnormal_immune_serum | 2.41134043 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.40510367 |
| 19 | MP0001819_abnormal_immune_cell | 2.27861719 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.27279327 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.17425322 |
| 22 | MP0006082_CNS_inflammation | 2.12804099 |
| 23 | MP0009278_abnormal_bone_marrow | 2.04283528 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.99592990 |
| 25 | MP0005174_abnormal_tail_pigmentation | 1.96895374 |
| 26 | MP0005310_abnormal_salivary_gland | 1.95291525 |
| 27 | MP0003787_abnormal_imprinting | 1.93499243 |
| 28 | MP0002398_abnormal_bone_marrow | 1.88995227 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.87852838 |
| 30 | MP0000716_abnormal_immune_system | 1.81637214 |
| 31 | MP0004510_myositis | 1.80191910 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.75874925 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.75757267 |
| 34 | MP0002405_respiratory_system_inflammati | 1.75416522 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.74605703 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.74282803 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.71936754 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.71304121 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.70381669 |
| 40 | MP0004947_skin_inflammation | 1.69020419 |
| 41 | MP0003866_abnormal_defecation | 1.61420651 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.59782337 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.57350234 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.55589373 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.53412321 |
| 46 | MP0008469_abnormal_protein_level | 1.52270891 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.50993695 |
| 48 | MP0002429_abnormal_blood_cell | 1.48430143 |
| 49 | MP0002722_abnormal_immune_system | 1.46711756 |
| 50 | MP0001853_heart_inflammation | 1.44361007 |
| 51 | MP0008995_early_reproductive_senescence | 1.44107706 |
| 52 | MP0001873_stomach_inflammation | 1.43641470 |
| 53 | MP0009764_decreased_sensitivity_to | 1.39289849 |
| 54 | MP0005360_urolithiasis | 1.36721745 |
| 55 | MP0003283_abnormal_digestive_organ | 1.36503495 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.36107871 |
| 57 | MP0010234_abnormal_vibrissa_follicle | 1.35856143 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.35304934 |
| 59 | MP0008877_abnormal_DNA_methylation | 1.34678571 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.34348702 |
| 61 | MP0005365_abnormal_bile_salt | 1.32935225 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.31419869 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.31419869 |
| 64 | MP0001666_abnormal_nutrient_absorption | 1.23919303 |
| 65 | MP0005085_abnormal_gallbladder_physiolo | 1.23901851 |
| 66 | MP0009840_abnormal_foam_cell | 1.16178361 |
| 67 | MP0002006_tumorigenesis | 1.14374146 |
| 68 | MP0003252_abnormal_bile_duct | 1.13346773 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 1.12608765 |
| 70 | MP0000604_amyloidosis | 1.12450892 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 1.12151254 |
| 72 | MP0000015_abnormal_ear_pigmentation | 1.11924257 |
| 73 | MP0003011_delayed_dark_adaptation | 1.09256940 |
| 74 | MP0004142_abnormal_muscle_tone | 1.08428499 |
| 75 | MP0001986_abnormal_taste_sensitivity | 1.06298376 |
| 76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05892774 |
| 77 | MP0001663_abnormal_digestive_system | 1.04762113 |
| 78 | MP0004782_abnormal_surfactant_physiolog | 1.01083896 |
| 79 | MP0000490_abnormal_crypts_of | 0.99079635 |
| 80 | MP0003075_altered_response_to | 0.97559612 |
| 81 | MP0002095_abnormal_skin_pigmentation | 0.97032146 |
| 82 | MP0005451_abnormal_body_composition | 0.96769747 |
| 83 | MP0003045_fibrosis | 0.94534413 |
| 84 | MP0002132_abnormal_respiratory_system | 0.93931443 |
| 85 | MP0000858_altered_metastatic_potential | 0.93225832 |
| 86 | MP0005083_abnormal_biliary_tract | 0.92929189 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.92252298 |
| 88 | MP0008872_abnormal_physiological_respon | 0.90951564 |
| 89 | MP0001905_abnormal_dopamine_level | 0.88032357 |
| 90 | MP0003828_pulmonary_edema | 0.87754215 |
| 91 | MP0000372_irregular_coat_pigmentation | 0.87355964 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 0.86952522 |
| 93 | MP0010329_abnormal_lipoprotein_level | 0.86366727 |
| 94 | MP0001501_abnormal_sleep_pattern | 0.85569494 |
| 95 | MP0004147_increased_porphyrin_level | 0.83793418 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.83676794 |
| 97 | MP0004883_abnormal_blood_vessel | 0.83637852 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.83520390 |
| 99 | MP0004019_abnormal_vitamin_homeostasis | 0.83434316 |
| 100 | MP0009763_increased_sensitivity_to | 0.82798621 |
| 101 | MP0000343_altered_response_to | 0.82248801 |
| 102 | MP0005166_decreased_susceptibility_to | 0.79874741 |
| 103 | MP0004484_altered_response_of | 0.79714871 |
| 104 | MP0005381_digestive/alimentary_phenotyp | 0.79466744 |
| 105 | MP0000609_abnormal_liver_physiology | 0.78968978 |
| 106 | MP0002277_abnormal_respiratory_mucosa | 0.76543759 |
| 107 | MP0004885_abnormal_endolymph | 0.76113528 |
| 108 | MP0001851_eye_inflammation | 0.75902955 |
| 109 | MP0005535_abnormal_body_temperature | 0.73995608 |
| 110 | MP0008874_decreased_physiological_sensi | 0.73345380 |
| 111 | MP0004381_abnormal_hair_follicle | 0.73078269 |
| 112 | MP0001968_abnormal_touch/_nociception | 0.72956999 |
| 113 | MP0002933_joint_inflammation | 0.72646606 |
| 114 | MP0005379_endocrine/exocrine_gland_phen | 0.72335123 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72176751 |
| 116 | MP0002928_abnormal_bile_duct | 0.70149956 |
| 117 | MP0008004_abnormal_stomach_pH | 0.70114734 |
| 118 | MP0002733_abnormal_thermal_nociception | 0.69786207 |
| 119 | MP0009745_abnormal_behavioral_response | 0.68436674 |
| 120 | MP0006276_abnormal_autonomic_nervous | 0.67901391 |
| 121 | MP0003448_altered_tumor_morphology | 0.67830790 |
| 122 | MP0005084_abnormal_gallbladder_morpholo | 0.66867052 |
| 123 | MP0004043_abnormal_pH_regulation | 0.65412693 |
| 124 | MP0005636_abnormal_mineral_homeostasis | 0.63569982 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.63329946 |
| 126 | MP0004742_abnormal_vestibular_system | 0.63042758 |
| 127 | MP0003718_maternal_effect | 0.62057452 |
| 128 | MP0005551_abnormal_eye_electrophysiolog | 0.60516085 |
| 129 | MP0002693_abnormal_pancreas_physiology | 0.60339502 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.59072941 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.58833823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.09498830 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.76590894 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.37641059 |
| 4 | Posterior subcapsular cataract (HP:0007787) | 4.36738817 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.95130561 |
| 6 | Petechiae (HP:0000967) | 3.89946456 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.88363500 |
| 8 | Recurrent viral infections (HP:0004429) | 3.86464338 |
| 9 | Recurrent skin infections (HP:0001581) | 3.60495768 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 3.57169820 |
| 11 | Abnormality of B cell number (HP:0010975) | 3.44821284 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 3.43003812 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.43003812 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.35214269 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.32989527 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.29313684 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.18524745 |
| 18 | Meningitis (HP:0001287) | 3.18267823 |
| 19 | Autoimmune hemolytic anemia (HP:0001890) | 3.14417795 |
| 20 | Chronic otitis media (HP:0000389) | 3.13361154 |
| 21 | Agammaglobulinemia (HP:0004432) | 3.12118728 |
| 22 | Gingival bleeding (HP:0000225) | 3.10332316 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.09559524 |
| 24 | Obstructive lung disease (HP:0006536) | 3.09559524 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.06016330 |
| 26 | Myositis (HP:0100614) | 3.04290358 |
| 27 | Gingivitis (HP:0000230) | 2.98159361 |
| 28 | Stomach cancer (HP:0012126) | 2.97864206 |
| 29 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.96354432 |
| 30 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.94412892 |
| 31 | Prolonged bleeding time (HP:0003010) | 2.93747126 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 2.87353218 |
| 33 | Epistaxis (HP:0000421) | 2.82871930 |
| 34 | Pustule (HP:0200039) | 2.81453107 |
| 35 | Vasculitis (HP:0002633) | 2.80567950 |
| 36 | Dysostosis multiplex (HP:0000943) | 2.78967513 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 2.75928088 |
| 38 | Acute lymphatic leukemia (HP:0006721) | 2.73005019 |
| 39 | Periodontitis (HP:0000704) | 2.67583645 |
| 40 | Cellulitis (HP:0100658) | 2.66544921 |
| 41 | Flat capital femoral epiphysis (HP:0003370) | 2.64609576 |
| 42 | Stomatitis (HP:0010280) | 2.59444946 |
| 43 | IgM deficiency (HP:0002850) | 2.59405373 |
| 44 | B lymphocytopenia (HP:0010976) | 2.59182250 |
| 45 | Aplastic anemia (HP:0001915) | 2.57950262 |
| 46 | Interstitial pulmonary disease (HP:0006530) | 2.57319862 |
| 47 | Increased IgE level (HP:0003212) | 2.56997527 |
| 48 | Inflammation of the large intestine (HP:0002037) | 2.56900175 |
| 49 | Joint hemorrhage (HP:0005261) | 2.56504196 |
| 50 | Abnormality of T cell physiology (HP:0011840) | 2.52898589 |
| 51 | Renal cortical cysts (HP:0000803) | 2.52236426 |
| 52 | Colitis (HP:0002583) | 2.51384601 |
| 53 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.50622158 |
| 54 | Abnormality of eosinophils (HP:0001879) | 2.48749776 |
| 55 | Optic neuritis (HP:0100653) | 2.47747574 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 2.47747574 |
| 57 | Flat acetabular roof (HP:0003180) | 2.43678222 |
| 58 | Gastrointestinal infarctions (HP:0005244) | 2.40613554 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.37634473 |
| 60 | Orchitis (HP:0100796) | 2.37167057 |
| 61 | Chest pain (HP:0100749) | 2.34017526 |
| 62 | Abnormality of T cells (HP:0002843) | 2.31120560 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.30916961 |
| 64 | Abnormality of the prostate (HP:0008775) | 2.30408813 |
| 65 | Encephalitis (HP:0002383) | 2.30329843 |
| 66 | Abnormality of the thoracic spine (HP:0100711) | 2.28823575 |
| 67 | Congenital stationary night blindness (HP:0007642) | 2.28779203 |
| 68 | Leukocytosis (HP:0001974) | 2.27657559 |
| 69 | Menorrhagia (HP:0000132) | 2.27576782 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 2.26470985 |
| 71 | Urticaria (HP:0001025) | 2.25016703 |
| 72 | Exertional dyspnea (HP:0002875) | 2.24965660 |
| 73 | Abnormal platelet function (HP:0011869) | 2.21571347 |
| 74 | Impaired platelet aggregation (HP:0003540) | 2.21571347 |
| 75 | Spontaneous hematomas (HP:0007420) | 2.20955379 |
| 76 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.20707383 |
| 77 | Abnormal platelet volume (HP:0011876) | 2.20025536 |
| 78 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18313413 |
| 79 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18313413 |
| 80 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18313413 |
| 81 | Joint swelling (HP:0001386) | 2.18291984 |
| 82 | Purpura (HP:0000979) | 2.16960257 |
| 83 | Thoracic kyphosis (HP:0002942) | 2.16711330 |
| 84 | Subcapsular cataract (HP:0000523) | 2.16186648 |
| 85 | Chronic diarrhea (HP:0002028) | 2.15530834 |
| 86 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.14705592 |
| 87 | Recurrent bronchitis (HP:0002837) | 2.14374033 |
| 88 | Large earlobe (HP:0009748) | 2.13138610 |
| 89 | Keratoconjunctivitis sicca (HP:0001097) | 2.12265683 |
| 90 | Severe combined immunodeficiency (HP:0004430) | 2.11696881 |
| 91 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11623424 |
| 92 | Granulocytopenia (HP:0001913) | 2.10630011 |
| 93 | Vertigo (HP:0002321) | 2.10102601 |
| 94 | Myocardial infarction (HP:0001658) | 2.09313420 |
| 95 | Eosinophilia (HP:0001880) | 2.08776132 |
| 96 | Increased IgM level (HP:0003496) | 2.07784106 |
| 97 | Recurrent sinusitis (HP:0011108) | 2.07024005 |
| 98 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06444673 |
| 99 | Mucopolysacchariduria (HP:0008155) | 2.06444673 |
| 100 | Thrombocytosis (HP:0001894) | 2.05514216 |
| 101 | Abnormality of T cell number (HP:0011839) | 2.05081136 |
| 102 | Hip dysplasia (HP:0001385) | 2.04907104 |
| 103 | Flattened epiphyses (HP:0003071) | 2.04805516 |
| 104 | Abnormality of DNA repair (HP:0003254) | 2.04386098 |
| 105 | T lymphocytopenia (HP:0005403) | 2.04204827 |
| 106 | Osteomyelitis (HP:0002754) | 2.03330565 |
| 107 | Arterial thrombosis (HP:0004420) | 2.03254145 |
| 108 | Keratoconjunctivitis (HP:0001096) | 2.02985748 |
| 109 | Abnormality of lateral ventricle (HP:0030047) | 2.02229991 |
| 110 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01327285 |
| 111 | Thyroiditis (HP:0100646) | 2.00607965 |
| 112 | Poikilocytosis (HP:0004447) | 1.99986780 |
| 113 | Cheilitis (HP:0100825) | 1.99337270 |
| 114 | Hypergammaglobulinemia (HP:0010702) | 1.99312340 |
| 115 | Progressive visual loss (HP:0000529) | 1.98876033 |
| 116 | Abnormality of glycolipid metabolism (HP:0010969) | 1.97786182 |
| 117 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.97786182 |
| 118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.97786182 |
| 119 | Recurrent pneumonia (HP:0006532) | 1.96998368 |
| 120 | Hemoptysis (HP:0002105) | 1.96143157 |
| 121 | Combined immunodeficiency (HP:0005387) | 1.95597726 |
| 122 | Prolonged partial thromboplastin time (HP:0003645) | 1.94606935 |
| 123 | Thyroid-stimulating hormone excess (HP:0002925) | 1.94590612 |
| 124 | Decreased central vision (HP:0007663) | 1.92530542 |
| 125 | Amaurosis fugax (HP:0100576) | 1.88908260 |
| 126 | IgG deficiency (HP:0004315) | 1.88288503 |
| 127 | Pulmonary embolism (HP:0002204) | 1.87957118 |
| 128 | Abnormality of the renal cortex (HP:0011035) | 1.84412682 |
| 129 | Hemiplegia (HP:0002301) | 1.83961074 |
| 130 | Neutropenia (HP:0001875) | 1.83072135 |
| 131 | Skin rash (HP:0000988) | 1.82315851 |
| 132 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.81354624 |
| 133 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80911289 |
| 134 | Abnormality of iron homeostasis (HP:0011031) | 1.80586052 |
| 135 | Sepsis (HP:0100806) | 1.78904963 |
| 136 | Neurodegeneration (HP:0002180) | 1.77292832 |
| 137 | Alveolar cell carcinoma (HP:0006519) | 1.76708489 |
| 138 | Chronic sinusitis (HP:0011109) | 1.75967006 |
| 139 | Hypochromic anemia (HP:0001931) | 1.75463573 |
| 140 | Abnormality of the renal collecting system (HP:0004742) | 1.75280852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.98436716 |
| 2 | MAP3K14 | 3.56969220 |
| 3 | BLK | 3.34149412 |
| 4 | RIPK4 | 3.18304631 |
| 5 | IRAK4 | 2.93845655 |
| 6 | KIT | 2.84545770 |
| 7 | * TAOK3 | 2.82054233 |
| 8 | MAP3K13 | 2.81525288 |
| 9 | TXK | 2.80202298 |
| 10 | TYK2 | 2.65927020 |
| 11 | TBK1 | 2.12292597 |
| 12 | JAK3 | 2.03606826 |
| 13 | IKBKE | 2.01558530 |
| 14 | BTK | 2.00115428 |
| 15 | GRK6 | 1.96038820 |
| 16 | SYK | 1.95001921 |
| 17 | FES | 1.94643982 |
| 18 | BCKDK | 1.91416694 |
| 19 | TEC | 1.86540995 |
| 20 | EPHB2 | 1.84839245 |
| 21 | IRAK3 | 1.84668060 |
| 22 | PIM2 | 1.79903590 |
| 23 | ZAP70 | 1.79135483 |
| 24 | JAK1 | 1.70496577 |
| 25 | MAPK13 | 1.67781850 |
| 26 | ITK | 1.59939872 |
| 27 | CSF1R | 1.55060839 |
| 28 | MAP3K12 | 1.53660197 |
| 29 | IKBKB | 1.52491721 |
| 30 | MAP2K3 | 1.47282713 |
| 31 | FRK | 1.38921602 |
| 32 | LCK | 1.32440161 |
| 33 | LYN | 1.30235694 |
| 34 | CSK | 1.29492576 |
| 35 | CLK1 | 1.28967444 |
| 36 | SIK2 | 1.28856589 |
| 37 | ERN1 | 1.12548246 |
| 38 | MAP3K11 | 1.09743742 |
| 39 | HCK | 1.09365662 |
| 40 | JAK2 | 1.07212059 |
| 41 | DAPK2 | 1.06402814 |
| 42 | PINK1 | 1.05107358 |
| 43 | STK10 | 1.05081075 |
| 44 | EPHB1 | 1.03082139 |
| 45 | FGFR4 | 1.02414606 |
| 46 | GRK1 | 1.02125014 |
| 47 | PRKCQ | 1.00944533 |
| 48 | CHUK | 0.98563116 |
| 49 | MATK | 0.95457319 |
| 50 | TESK2 | 0.91656139 |
| 51 | MAP4K2 | 0.89653604 |
| 52 | PBK | 0.87526676 |
| 53 | PIM1 | 0.87411285 |
| 54 | RIPK1 | 0.87222899 |
| 55 | MARK3 | 0.83147727 |
| 56 | HIPK2 | 0.80742851 |
| 57 | FLT3 | 0.78929011 |
| 58 | BMPR2 | 0.76687270 |
| 59 | TAOK1 | 0.72849130 |
| 60 | INSRR | 0.72141543 |
| 61 | MAPK11 | 0.69542778 |
| 62 | CAMK1G | 0.68835326 |
| 63 | MAPK12 | 0.67503444 |
| 64 | MAP2K4 | 0.67079774 |
| 65 | NEK9 | 0.66826740 |
| 66 | MAP3K5 | 0.64547126 |
| 67 | TNK2 | 0.61977660 |
| 68 | MAP3K4 | 0.59714674 |
| 69 | BMPR1B | 0.59686816 |
| 70 | MAP3K6 | 0.58141560 |
| 71 | PIK3CG | 0.57533115 |
| 72 | MAP3K9 | 0.54751384 |
| 73 | PTK2B | 0.54595383 |
| 74 | MAP3K1 | 0.53970464 |
| 75 | RPS6KA5 | 0.53351236 |
| 76 | FGR | 0.52413068 |
| 77 | PRKD2 | 0.52350383 |
| 78 | GRK5 | 0.51720151 |
| 79 | NTRK2 | 0.51152740 |
| 80 | CDK19 | 0.50414164 |
| 81 | GRK7 | 0.50311930 |
| 82 | CAMKK2 | 0.49309138 |
| 83 | ABL1 | 0.47771751 |
| 84 | TNIK | 0.47667499 |
| 85 | SGK2 | 0.47648555 |
| 86 | NME2 | 0.47633454 |
| 87 | PRPF4B | 0.47533047 |
| 88 | PKN1 | 0.46232268 |
| 89 | MAP2K7 | 0.45886339 |
| 90 | STK4 | 0.45649102 |
| 91 | TGFBR2 | 0.45316807 |
| 92 | PDK1 | 0.45265376 |
| 93 | MAP2K6 | 0.44815756 |
| 94 | MAPK4 | 0.44746708 |
| 95 | ABL2 | 0.43410565 |
| 96 | PIK3CA | 0.42962602 |
| 97 | NUAK1 | 0.42357947 |
| 98 | EGFR | 0.41248308 |
| 99 | MAPK7 | 0.41102496 |
| 100 | PRKCD | 0.39966866 |
| 101 | RAF1 | 0.39563501 |
| 102 | MAP2K2 | 0.39384251 |
| 103 | MOS | 0.39090449 |
| 104 | PRKG2 | 0.38795603 |
| 105 | ADRBK1 | 0.38218325 |
| 106 | SGK1 | 0.37596964 |
| 107 | IGF1R | 0.37520617 |
| 108 | IRAK1 | 0.37178116 |
| 109 | YES1 | 0.37101362 |
| 110 | FYN | 0.37041671 |
| 111 | TRPM7 | 0.36266932 |
| 112 | FGFR3 | 0.34873354 |
| 113 | MAPK15 | 0.33963852 |
| 114 | DAPK1 | 0.33324792 |
| 115 | PRKAA2 | 0.33204297 |
| 116 | ADRBK2 | 0.33054538 |
| 117 | CDK3 | 0.33047423 |
| 118 | RPS6KA6 | 0.32080360 |
| 119 | PTK6 | 0.31837740 |
| 120 | ARAF | 0.31100407 |
| 121 | EPHA3 | 0.30924395 |
| 122 | NTRK3 | 0.29111366 |
| 123 | MARK2 | 0.28889752 |
| 124 | OXSR1 | 0.28879328 |
| 125 | PDPK1 | 0.27112215 |
| 126 | NLK | 0.26746474 |
| 127 | NEK6 | 0.25708202 |
| 128 | MAPK3 | 0.25440226 |
| 129 | PRKD1 | 0.25345316 |
| 130 | SRC | 0.25246871 |
| 131 | MAPKAPK2 | 0.24996549 |
| 132 | CDK6 | 0.24627760 |
| 133 | DYRK1A | 0.24542779 |
| 134 | SGK3 | 0.23998167 |
| 135 | PRKCA | 0.22656973 |
| 136 | ILK | 0.22384239 |
| 137 | PRKG1 | 0.22333763 |
| 138 | CCNB1 | 0.22224416 |
| 139 | TLK1 | 0.22065597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.88566975 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.84489225 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.64502299 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.48067110 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.39915525 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.36678403 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.35658527 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.27176006 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.12489262 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.07249144 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.97558396 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.89270995 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.85946346 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81713873 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.77584002 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.72966139 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.71913073 |
| 18 | Phototransduction_Homo sapiens_hsa04744 | 1.69261071 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66570253 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.64843160 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63969099 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.63077990 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59652085 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58720475 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56522046 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.54630046 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52953382 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.46573993 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.43161057 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.42203413 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38630494 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.36830174 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36144659 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35955601 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35281441 |
| 36 | Asthma_Homo sapiens_hsa05310 | 1.33398482 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.32065550 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.30472463 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27455818 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.19747540 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.19535444 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18586058 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16794652 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16429663 |
| 45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.13513945 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.12332865 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.09895013 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.06540562 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.05907190 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.03901125 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.01258933 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 1.00865743 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00019623 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.99046989 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.95213257 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93928466 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91964906 |
| 58 | Olfactory transduction_Homo sapiens_hsa04740 | 0.91141725 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90898573 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89943418 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89401192 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87852269 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83261765 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82182028 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79793014 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77739179 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77081903 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76314276 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76063738 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75515185 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74943519 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74856015 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69963631 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69929180 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68407689 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67911115 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67790512 |
| 78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64647478 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64055348 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64013643 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62991761 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61572386 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60890852 |
| 84 | Morphine addiction_Homo sapiens_hsa05032 | 0.60253189 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.59291085 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58924512 |
| 87 | Salivary secretion_Homo sapiens_hsa04970 | 0.58348844 |
| 88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56853127 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53512967 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53106112 |
| 91 | Long-term depression_Homo sapiens_hsa04730 | 0.48440465 |
| 92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47951691 |
| 93 | Nicotine addiction_Homo sapiens_hsa05033 | 0.47922439 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.47471921 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47461120 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.46688770 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.46659956 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.44017025 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43514442 |
| 100 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.43504989 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42792982 |
| 102 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42451259 |
| 103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42215014 |
| 104 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.41709219 |
| 105 | Taste transduction_Homo sapiens_hsa04742 | 0.41269327 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39778445 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39673488 |
| 108 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.39131396 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38352763 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.38180706 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37506011 |
| 112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37265879 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36596897 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34620123 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34259124 |
| 116 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.33521657 |
| 117 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32108405 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32036311 |
| 119 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31936989 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31894334 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31424568 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30885585 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28845289 |
| 124 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28762696 |
| 125 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27341463 |
| 126 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.25782402 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25550901 |
| 128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25541702 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24915739 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.22176748 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21678578 |
| 132 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.21322347 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20457111 |

